SLC35D3 and metabolic syndrome: The restricted expression of SLC35D3 in the brain and the absence of expression in other peripheral organs (except for the platelets) laid the foundation of our hypothesis that the MetS phenotype in ros mice is attributable to lesions in the central nervous system.